{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:19:09Z","timestamp":1757618349902,"version":"3.44.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Melatonin is synthesised during the dark phase of the day, and its biosynthesis is inhibited by light. Exogenously supplied melatonin has been reported to have hypotensive effects. However, in animal experiments, melatonin is usually administered in one high dose and blood pressure (BP) is almost exclusively measured by plethysmography during the light phase of the day. We tested the effects of melatonin administration in drinking water during the dark phase of the day at different concentrations (2\u201345\u2009mg\/kg\/12\u2009h) for three weeks and telemetrically measured haemodynamic variables in spontaneously hypertensive rats (SHR). We measured gene and protein expression in the hypothalamus, brainstem, kidney and adrenal gland. We did not observe a BP decrease even at the highest melatonin concentration. We observed a dose-dependent increase in the percent recovery point and a decrease in dP\/dt<jats:sub>max<\/jats:sub>, particularly during the light phase at lower doses. The effects on the autonomic nervous system and baroreflex were equivocal, with changes observed in both experimental and placebo groups. Melatonin dose-dependently decreased vasopressin expression in the supraoptic nuclei. In the adrenal gland, melatonin increased tyrosine hydroxylase expression. In the kidney, low melatonin doses increased endothelial nitric oxide synthase, while higher doses decreased CD68 levels. Our results do not confirm the hypotensive effects of melatonin in SHR. The potential beneficial effects of melatonin could result from a long-term impact on various organs involved in BP regulation and interaction with multiple molecular pathways, some of which may manifest in improved cardiovascular health in the long term.<\/jats:p>","DOI":"10.1038\/s41440-025-02247-3","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T02:58:09Z","timestamp":1749437889000},"page":"2218-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dark-phase melatonin administration does not reduce blood pressure but induces changes in parameters related to the control of the cardiovascular system in spontaneously hypertensive rats"],"prefix":"10.1038","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8161-5888","authenticated-orcid":false,"given":"Hana","family":"Mauer Sutovska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2797-0149","authenticated-orcid":false,"given":"Lubos","family":"Molcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1754-5790","authenticated-orcid":false,"given":"Peter","family":"Stefanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-6805","authenticated-orcid":false,"given":"Michal","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"2247_CR1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41440-022-01031-x","volume":"45","author":"D Cvikova","year":"2022","unstructured":"Cvikova D, Sutovska H, Babarikova K, Molcan L. Hypotensive effects of melatonin in rats: focus on the model, measurement, application, and main mechanisms. Hypertens Res. 2022;45:1929\u201344. https:\/\/doi.org\/10.1038\/s41440-022-01031-x.","journal-title":"Hypertens Res"},{"key":"2247_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.888319","volume":"9","author":"M Tobeiha","year":"2022","unstructured":"Tobeiha M, Jafari A, Fadaei S, Mirazimi SMA, Dashti F, Amiri A, et al. Evidence for the benefits of melatonin in cardiovascular disease. Front Cardiovasc Med. 2022;9:888319. https:\/\/doi.org\/10.3389\/fcvm.2022.888319.","journal-title":"Front Cardiovasc Med"},{"key":"2247_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/hr.2009.12","volume":"32","author":"M Benova","year":"2009","unstructured":"Benova M, Herichova I, Stebelova K, Paulis L, Krajcirovicova K, Simko F, et al. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats. Hypertens Res. 2009;32:242\u20137. https:\/\/doi.org\/10.1038\/hr.2009.12.","journal-title":"Hypertens Res"},{"key":"2247_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.lfs.2004.08.016","volume":"76","author":"P Sallinen","year":"2005","unstructured":"Sallinen P, Saarela S, Ilves M, Vakkuri O, Lepp\u00e4luoto J. The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues. Life Sci. 2005;76:1123\u201334.","journal-title":"Life Sci"},{"key":"2247_CR5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10571-011-9727-9","volume":"31","author":"M Schepelmann","year":"2011","unstructured":"Schepelmann M, Molcan L, Uhrova H, Zeman M, Ellinger I. The presence and localization of melatonin receptors in the rat aorta. Cell Mol Neurobiol. 2011;31:1257\u201365. https:\/\/doi.org\/10.1007\/s10571-011-9727-9.","journal-title":"Cell Mol Neurobiol"},{"key":"2247_CR6","doi-asserted-by":"publisher","unstructured":"Molcan L, Maier A, Zeman\u010d\u00edkov\u00e1 A, Gelles K, T\u00f6r\u00f6k J, Zeman M, et al. Expression of melatonin receptor 1 in rat mesenteric artery and perivascular adipose tissue and vasoactive action of melatonin. Cell Mol Neurobiol. 2020. https:\/\/doi.org\/10.1007\/s10571-020-00928-w.","DOI":"10.1007\/s10571-020-00928-w"},{"key":"2247_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bjp.0702612","volume":"127","author":"KN Ting","year":"1999","unstructured":"Ting KN, Blaylock NA, Sugden D, Delagrange P, Scalbert E, Wilson VG. Molecular and pharmacological evidence for MT 1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol. 1999;127:987\u201395. https:\/\/doi.org\/10.1038\/sj.bjp.0702612.","journal-title":"Br J Pharmacol"},{"key":"2247_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1124\/jpet.302.3.1295","volume":"302","author":"MI Masana","year":"2002","unstructured":"Masana MI, Doolen S, Ersahin C, Al-Ghoul WM, Duckles SP, Dubocovich ML, et al. MT2 melatonin receptors are present and functional in rat caudal artery. J Pharm Exp Ther. 2002;302:1295\u2013302. https:\/\/doi.org\/10.1124\/jpet.302.3.1295.","journal-title":"J Pharm Exp Ther"},{"key":"2247_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/hr.2016.103","volume":"40","author":"C Agabiti-Rosei","year":"2017","unstructured":"Agabiti-Rosei C, Favero G, De Ciuceis C, Rossini C, Porteri E, Rodella LF, et al. Effect of long-term treatment with melatonin on vascular markers of oxidative stress\/inflammation and on the anticontractile activity of perivascular fat in aging mice. Hypertens Res. 2017;40:41\u201350. https:\/\/doi.org\/10.1038\/hr.2016.103.","journal-title":"Hypertens Res"},{"key":"2247_CR10","doi-asserted-by":"publisher","first-page":"112330","DOI":"10.1016\/j.mce.2024.112330","volume":"592","author":"CD Lisboa","year":"2024","unstructured":"Lisboa CD, Maciel de Souza JL, Gaspar CJ, Turck P, Ortiz VD, Teixeira Proen\u00e7a IC, et al. Melatonin effects on oxidative stress and on TLR4\/NF-k\u03b2 inflammatory pathway in the right ventricle of rats with pulmonary arterial hypertension. Mol Cell Endocrinol. 2024;592:112330. https:\/\/doi.org\/10.1016\/j.mce.2024.112330.","journal-title":"Mol Cell Endocrinol"},{"key":"2247_CR11","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.3390\/ijms25073763","volume":"25","author":"R Nachiappa Ganesh","year":"2024","unstructured":"Nachiappa Ganesh R, Garcia G, Truong L. Monocytes and macrophages in kidney disease and homeostasis. IJMS. 2024;25:3763. https:\/\/doi.org\/10.3390\/ijms25073763.","journal-title":"IJMS"},{"key":"2247_CR12","doi-asserted-by":"publisher","first-page":"1166246","DOI":"10.3389\/fphys.2023.1166246","volume":"14","author":"Q Yu","year":"2023","unstructured":"Yu Q, Guo Q, Jin S, Gao C, Zheng P, Li DP, et al. Melatonin suppresses sympathetic vasomotor tone through enhancing GABAA receptor activity in the hypothalamus. Front Physiol. 2023;14:1166246. https:\/\/doi.org\/10.3389\/fphys.2023.1166246.","journal-title":"Front Physiol"},{"key":"2247_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-079X.1994.tb00095.x","volume":"16","author":"AI Esquifino","year":"1994","unstructured":"Esquifino AI, Moreno ML, Steger RW. Effects of chronic melatonin administration on adrenal medulla catecholamine metabolism in adult male golden hamsters. J Pineal Res. 1994;16:154\u20138. https:\/\/doi.org\/10.1111\/j.1600-079X.1994.tb00095.x.","journal-title":"J Pineal Res"},{"key":"2247_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44277-024-00002-z","volume":"2","author":"JA Frie","year":"2024","unstructured":"Frie JA, Khokhar JY. FARESHARE: an open-source apparatus for assessing drinking microstructure in socially housed rats. NPP Digit Psychiatry Neurosci. 2024;2:1 https:\/\/doi.org\/10.1038\/s44277-024-00002-z.","journal-title":"NPP Digit Psychiatry Neurosci"},{"key":"2247_CR15","doi-asserted-by":"publisher","first-page":"113620","DOI":"10.1016\/j.physbeh.2021.113620","volume":"242","author":"L Molcan","year":"2021","unstructured":"Molcan L. Telemetric data collection should be standard in modern experimental cardiovascular research. Physiol Behav. 2021;242:113620. https:\/\/doi.org\/10.1016\/j.physbeh.2021.113620.","journal-title":"Physiol Behav"},{"key":"2247_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/hr.2016.21","volume":"39","author":"P Svitok","year":"2016","unstructured":"Svitok P, Molcan L, Stebelova K, Vesela A, Sedlackova N, Ujhazy E, et al. Prenatal hypoxia in rats increased blood pressure and sympathetic drive of the adult offspring. Hypertens Res. 2016;39:501\u20135. https:\/\/doi.org\/10.1038\/hr.2016.21.","journal-title":"Hypertens Res"},{"key":"2247_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10571-010-9612-y","volume":"31","author":"Z Dzirb\u00edkov\u00e1","year":"2011","unstructured":"Dzirb\u00edkov\u00e1 Z, Kiss A, Okuliarov\u00e1 M, Kopkan L, \u010cervenka L, Zeman M. Expressions of per1 clock gene and genes of signaling peptides vasopressin, vasoactive intestinal peptide, and oxytocin in the suprachiasmatic and paraventricular nuclei of hypertensive TGR[mREN2]27 rats. Cell Mol Neurobiol. 2011;31:225\u201332. https:\/\/doi.org\/10.1007\/s10571-010-9612-y.","journal-title":"Cell Mol Neurobiol"},{"key":"2247_CR18","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1210\/endo.141.11.7767","volume":"141","author":"MB M\u00fcller","year":"2000","unstructured":"M\u00fcller MB, Landgraf R, Preil J, Sillaber I, Kresse AE, Keck ME, et al. Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology. 2000;141:4262\u20139. https:\/\/doi.org\/10.1210\/endo.141.11.7767.","journal-title":"Endocrinology"},{"key":"2247_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","volume":"7","author":"MG Erlander","year":"1991","unstructured":"Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylases. Neuron. 1991;7:91\u2013100. https:\/\/doi.org\/10.1016\/0896-6273(91)90077-D.","journal-title":"Neuron"},{"key":"2247_CR20","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1523\/JNEUROSCI.07-09-02768.1987","volume":"7","author":"Y Kobayashi","year":"1987","unstructured":"Kobayashi Y, Kaufman D, Tobin A. Glutamic acid decarboxylase cDNA: nucleotide sequence encoding an enzymatically active fusion protein. J Neurosci. 1987;7:2768\u201372. https:\/\/doi.org\/10.1523\/JNEUROSCI.07-09-02768.1987.","journal-title":"J Neurosci"},{"key":"2247_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0306-4522(93)90182-F","volume":"52","author":"C Gambarana","year":"1993","unstructured":"Gambarana C, Loria CJ, Siegel RE. GABAA receptor messenger RNA expression in the deep cerebellar nuclei of Purkinje cell degeneration mutants is maintained following the loss of innervating Purkinje neurons. Neuroscience. 1993;52:63\u201371. https:\/\/doi.org\/10.1016\/0306-4522(93)90182-F.","journal-title":"Neuroscience"},{"key":"2247_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.1975955","volume":"249","author":"J Guastella","year":"1990","unstructured":"Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, et al. Cloning and expression of a rat brain GABA transporter. Science. 1990;249:1303\u20136. https:\/\/doi.org\/10.1126\/science.1975955.","journal-title":"Science"},{"key":"2247_CR23","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press; 1998. https:\/\/books.google.sk\/books?id=2hp5QgAACAAJ."},{"key":"2247_CR24","doi-asserted-by":"publisher","unstructured":"Ramshur JT. Design, evaluation, and application of Heart Rate Variability Analysis Software (HRVAS). 2010. https:\/\/doi.org\/10.13140\/RG.2.2.33667.81444.","DOI":"10.13140\/RG.2.2.33667.81444"},{"key":"2247_CR25","unstructured":"Zuther P, Gorbey S, Lemmer B. Chronos-Fit 1.06. Chronos-Fit. 2009. http:\/\/www.ma.uni-heidelberg.de\/inst\/phar\/lehre\/chrono.html."},{"key":"2247_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1046\/j.1365-2125.2000.00195.x","volume":"49","author":"P Lusardi","year":"2000","unstructured":"Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24\u2010hour study. Brit J Clin Pharma. 2000;49:423\u20137. https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00195.x.","journal-title":"Brit J Clin Pharma"},{"key":"2247_CR27","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.lfs.2004.08.034","volume":"76","author":"M Zeman","year":"2005","unstructured":"Zeman M, Dulkov\u00e1 K, Bada V, Herichov\u00e1 I. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci. 2005;76:1795\u2013803. https:\/\/doi.org\/10.1016\/j.lfs.2004.08.034.","journal-title":"Life Sci"},{"key":"2247_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biopha.2006.01.002","volume":"60","author":"C Ekmekcioglu","year":"2006","unstructured":"Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother. 2006;60:97\u2013108. https:\/\/doi.org\/10.1016\/j.biopha.2006.01.002.","journal-title":"Biomed Pharmacother"},{"key":"2247_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2147\/VHRM.S24603","volume":"7","author":"E Grossman","year":"2011","unstructured":"Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag. 2011;7:577\u201384. https:\/\/doi.org\/10.2147\/VHRM.S24603.","journal-title":"Vasc Health Risk Manag"},{"key":"2247_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-2999(98)00064-8","volume":"345","author":"S Doolen","year":"1998","unstructured":"Doolen S, Krause DN, Dubocovich ML, Duckles SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol. 1998;345:67\u20139.","journal-title":"Eur J Pharmacol"},{"key":"2247_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1536\/ihj.34.491","volume":"34","author":"T Yamasaki","year":"1993","unstructured":"Yamasaki T, Negishi T, Fujimoto K, Suzuki T, Kawashima K. Effects of melatonin on blood pressure, heart rate and activity in conscious, freely moving stroke-prone spontaneously hypertensive rats as determined by a radiotelemetry system. Jpn Heart J. 1993;34:491. https:\/\/doi.org\/10.1536\/ihj.34.491.","journal-title":"Jpn Heart J"},{"key":"2247_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/107424840400900205","volume":"9","author":"SA Briaud","year":"2004","unstructured":"Briaud SA, Zhang BL, Sannajust F. Continuous light exposure and sympathectomy suppress circadian rhythm of blood pressure in rats. J Cardiovasc Pharm Ther. 2004;9:97\u2013105. https:\/\/doi.org\/10.1177\/107424840400900205.","journal-title":"J Cardiovasc Pharm Ther"},{"key":"2247_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1590\/S0100-879X1998000700002","volume":"31","author":"JM Marshall","year":"1998","unstructured":"Marshall JM. Chemoreceptors and cardiovascular control in acute and chronic systemic hypoxia. Braz J Med Biol Res. 1998;31:863\u201388.","journal-title":"Braz J Med Biol Res"},{"key":"2247_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41440-023-01199-w","volume":"46","author":"K Narita","year":"2023","unstructured":"Narita K, Hoshide S, Kario K. Short- to long-term blood pressure variability: current evidence and new evaluations. Hypertens Res. 2023;46:950\u20138. https:\/\/doi.org\/10.1038\/s41440-023-01199-w.","journal-title":"Hypertens Res"},{"key":"2247_CR35","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41440-024-01640-8","volume":"47","author":"L Molcan","year":"2024","unstructured":"Molcan L. Short-term blood pressure variability and reduced cytosolic calcium levels. Hypertens Res. 2024;47:1425\u20138. https:\/\/doi.org\/10.1038\/s41440-024-01640-8.","journal-title":"Hypertens Res"},{"key":"2247_CR36","doi-asserted-by":"publisher","unstructured":"Jiang D, Matsuzaki M, Ida T, Kitamura K, Kato J. Effects of vasodilators on beat-to-beat and every fifteen minutes blood pressure variability induced by noradrenaline infusion in rats. Hypertens Res. 2024. https:\/\/doi.org\/10.1038\/s41440-024-01595-w.","DOI":"10.1038\/s41440-024-01595-w"},{"key":"2247_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122179","volume":"333","author":"K Babarikova","year":"2023","unstructured":"Babarikova K, Svitok P, Kopkan L, Zeman M, Molcan L. Decreased sympathetic nerve activity in young hypertensive rats reared by normotensive mothers. Life Sci. 2023;333:122179 https:\/\/doi.org\/10.1016\/j.lfs.2023.122179.","journal-title":"Life Sci"},{"key":"2247_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111967","volume":"572","author":"H Sutovska","year":"2023","unstructured":"Sutovska H, Molcan L, Majzunova M, Sykora M, Kopkan L, Zeman M. Mineralocorticoid receptor blockade protects the kidneys but does not affect inverted blood pressure rhythm in hypertensive transgenic (mRen-2)27 rats. Mol Cell Endocrinol. 2023;572:111967. https:\/\/doi.org\/10.1016\/j.mce.2023.111967.","journal-title":"Mol Cell Endocrinol"},{"key":"2247_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1017\/S2040174420000963","volume":"12","author":"H Sutovska","year":"2021","unstructured":"Sutovska H, Molcan L, Koprdova R, Piesova M, Mach M, Zeman M. Prenatal hypoxia increases blood pressure in male rat offspring and affects their response to artificial light at night. J Dev Orig Health Dis. 2021;12:587\u201394. https:\/\/doi.org\/10.1017\/S2040174420000963.","journal-title":"J Dev Orig Health Dis"},{"key":"2247_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/07420529808998678","volume":"15","author":"K Witte","year":"1998","unstructured":"Witte K, Schnecko A, Buijs RM, van der Vliet J, Scalbert E, Delagrange P, et al. Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol Int. 1998;15:135\u201345. https:\/\/doi.org\/10.3109\/07420529808998678.","journal-title":"Chronobiol Int"},{"key":"2247_CR41","doi-asserted-by":"publisher","first-page":"R615","DOI":"10.1152\/ajpregu.1993.264.3.R615","volume":"264","author":"RR Margraf","year":"1993","unstructured":"Margraf RR, Lynch GR. Melatonin injections affect circadian behavior and SCN neurophysiology in Djungarian hamsters. Am J Physiol Regul Integr Comp Physiol. 1993;264:R615\u201321. https:\/\/doi.org\/10.1152\/ajpregu.1993.264.3.R615.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2247_CR42","doi-asserted-by":"publisher","unstructured":"Slotten H, Pitrosky B, P\u00e9vet P. Entrainment of rat circadian rhythms by daily administration of melatonin: influence of the mode of administration. In: Olcese J, editor. Melatonin after four decades. Adv Exp Med Biol. 2002:460;279\u201381. https:\/\/doi.org\/10.1007\/0-306-46814-X_30.","DOI":"10.1007\/0-306-46814-X_30"},{"key":"2247_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/07420528.2010.525675","volume":"28","author":"RA Peliciari-Garcia","year":"2011","unstructured":"Peliciari-Garcia RA, Zanquetta MM, Andrade-Silva J, Gomes DA, Barreto-Chaves ML, Cipolla-Neto J. Expression of circadian clock and melatonin receptors within cultured rat cardiomyocytes. Chronobiol Int. 2011;28:21\u201330. https:\/\/doi.org\/10.3109\/07420528.2010.525675.","journal-title":"Chronobiol Int"},{"key":"2247_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep14916","volume":"5","author":"BA Pellman","year":"2015","unstructured":"Pellman BA, Kim E, Reilly M, Kashima J, Motch O, de la Iglesia HO, et al. Time-specific fear acts as a non-photic entraining stimulus of circadian rhythms in Rats. Sci Rep. 2015;5:14916 https:\/\/doi.org\/10.1038\/srep14916.","journal-title":"Sci Rep"},{"key":"2247_CR45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-2826.2010.01956.x","volume":"22","author":"A Kalsbeek","year":"2010","unstructured":"Kalsbeek A, Fliers E, Hofman MA, Swaab DF, Buijs RM. Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol. 2010;22:362\u201372. https:\/\/doi.org\/10.1111\/j.1365-2826.2010.01956.x.","journal-title":"J Neuroendocrinol"},{"key":"2247_CR46","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1365-2826.2000.00479.x","volume":"12","author":"CK Song","year":"2000","unstructured":"Song CK, Bartness TJ, Petersen SL, Bittman EL. Co\u2010expression of melatonin (MEL 1a) receptor and arginine vasopressin mRNAs in the Siberian hamster suprachiasmatic nucleus. J Neuroendocrinol. 2000;12:627\u201334. https:\/\/doi.org\/10.1046\/j.1365-2826.2000.00479.x.","journal-title":"J Neuroendocrinol"},{"key":"2247_CR47","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/cne.21152","volume":"499","author":"YH Wu","year":"2006","unstructured":"Wu YH, Zhou JN, Balesar R, Unmehopa U, Bao A, Jockers R, et al. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin\u2010releasing hormone. J Comp Neurol. 2006;499:897\u2013910. https:\/\/doi.org\/10.1002\/cne.21152.","journal-title":"J Comp Neurol"},{"key":"2247_CR48","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/01.hjh.0000358833.41181.f6","volume":"27","author":"M Zeman","year":"2009","unstructured":"Zeman M, Sz\u00e1nt\u00f3ov\u00e1 K, Stebelov\u00e1 K, Mravec B, Herichov\u00e1 I. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats. J Hypertens. 2009;27:S21\u2013S26. https:\/\/doi.org\/10.1097\/01.hjh.0000358833.41181.f6.","journal-title":"J Hypertens"},{"key":"2247_CR49","doi-asserted-by":"crossref","unstructured":"Sl\u00e1dek M, Polidarov\u00e1 L, Nov\u00e1kov\u00e1 M, Parkanov\u00e1 D, Sumov\u00e1 A. Early chronotype and tissue-specific alterations of circadian clock function in spontaneously hypertensive rats. PLoS One. 2012;7:e46951.","DOI":"10.1371\/journal.pone.0046951"},{"key":"2247_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116568","volume":"231","author":"L Molcan","year":"2019","unstructured":"Molcan L, Sutovska H, Okuliarova M, Senko T, Krskova L, Zeman M. Dim light at night attenuates circadian rhythms in the cardiovascular system and suppresses melatonin in rats. Life Sci. 2019;231:116568. https:\/\/doi.org\/10.1016\/j.lfs.2019.116568.","journal-title":"Life Sci"},{"key":"2247_CR51","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41440-024-01685-9","volume":"47","author":"H Mauer Sutovska","year":"2024","unstructured":"Mauer Sutovska H, Obermajer V, Zeman M, Molcan L. Artificial light at night affects the daily profile of pulse pressure and protein expression in the thoracic aorta of rats. Hypertens Res. 2024;47:1897\u2013907. https:\/\/doi.org\/10.1038\/s41440-024-01685-9.","journal-title":"Hypertens Res"},{"key":"2247_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.autneu.2017.07.006","volume":"206","author":"L Molcan","year":"2017","unstructured":"Molcan L, Zeman M. Shifts in the light-dark cycle increase unpredictability of the cardiovascular system. Autonomic Neurosci. 2017;206:51\u20139. https:\/\/doi.org\/10.1016\/j.autneu.2017.07.006.","journal-title":"Autonomic Neurosci"},{"key":"2247_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ygcen.2017.05.013","volume":"258","author":"M Pfeffer","year":"2018","unstructured":"Pfeffer M, Korf HW, Wicht H. Synchronizing effects of melatonin on diurnal and circadian rhythms. Gen Comp Endocrinol. 2018;258:215\u201321. https:\/\/doi.org\/10.1016\/j.ygcen.2017.05.013.","journal-title":"Gen Comp Endocrinol"},{"key":"2247_CR54","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41440-018-0198-y","volume":"42","author":"A Vav\u0159\u00ednov\u00e1","year":"2019","unstructured":"Vav\u0159\u00ednov\u00e1 A, Behuliak M, Bencze M, Van\u011b\u010dkov\u00e1 I, Zicha J. Which sympathoadrenal abnormalities of adult spontaneously hypertensive rats can be traced to a prehypertensive stage? Hypertens Res. 2019;42:949\u201359. https:\/\/doi.org\/10.1038\/s41440-018-0198-y.","journal-title":"Hypertens Res"},{"key":"2247_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00004872-200301000-00028","volume":"21","author":"H Girouard","year":"2003","unstructured":"Girouard H, Chulak C, LeJossec M, Lamontagne D, de Champlain J. Chronic antioxidant treatment improves sympathetic functions and \u03b2-adrenergic pathway in the spontaneously hypertensive rats. J Hypertens. 2003;21:179\u201388. https:\/\/doi.org\/10.1097\/00004872-200301000-00028.","journal-title":"J Hypertens"},{"key":"2247_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0895-7061(97)00401-9","volume":"11","author":"A K.-Laflamme","year":"1998","unstructured":"K.-Laflamme A. Impaired basal sympathetic tone and \u03b11-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens. 1998;11:219\u201329. https:\/\/doi.org\/10.1016\/S0895-7061(97)00401-9.","journal-title":"Am J Hypertens"},{"key":"2247_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF00585172","volume":"397","author":"J Benessiano","year":"1983","unstructured":"Benessiano J, Levy B, Samuel JL, Leclercq JF, Safar M, Saumont R. Circadian changes in heart rate in unanesthetized normotensive and spontaneously hypertensive rats. Pflug Arch. 1983;397:70\u201372. https:\/\/doi.org\/10.1007\/BF00585172.","journal-title":"Pflug Arch"},{"key":"2247_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1748-1716.1984.tb00133.x","volume":"120","author":"S Lundin","year":"1984","unstructured":"Lundin S, Ricksten SE, Thor\u00e9n P. Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods. Acta Physiol Scand. 1984;120:265\u201372. https:\/\/doi.org\/10.1111\/j.1748-1716.1984.tb00133.x.","journal-title":"Acta Physiol Scand"},{"key":"2247_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/brb3.123","volume":"3","author":"LA Campos","year":"2013","unstructured":"Campos LA, Cipolla-Neto J, Michelini LC. Melatonin modulates baroreflex control via area postrema. Brain Behav. 2013;3:171\u20137. https:\/\/doi.org\/10.1002\/brb3.123.","journal-title":"Brain Behav"},{"key":"2247_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.autneu.2010.08.003","volume":"159","author":"TS Moreira","year":"2011","unstructured":"Moreira TS, Takakura AC, Colombari E. Important GABAergic mechanism within the NTS and the control of sympathetic baroreflex in SHR. Autonomic Neurosci. 2011;159:62\u201370. https:\/\/doi.org\/10.1016\/j.autneu.2010.08.003.","journal-title":"Autonomic Neurosci"},{"key":"2247_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/srep38447","volume":"6","author":"HH Chen","year":"2016","unstructured":"Chen HH, Cheng PW, Ho WY, Lu PJ, Lai CC, Tseng YM, et al. Renal denervation improves the baroreflex and GABA system in chronic kidney disease-induced hypertension. Sci Rep. 2016;6:38447. https:\/\/doi.org\/10.1038\/srep38447.","journal-title":"Sci Rep"},{"key":"2247_CR62","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.amjhyper.2004.06.009","volume":"17","author":"H Girouard","year":"2004","unstructured":"Girouard H, Denault C, Chulak C, Dechamplain J. Treatment by -acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am J Hypertens. 2004;17:947\u201354. https:\/\/doi.org\/10.1016\/j.amjhyper.2004.06.009.","journal-title":"Am J Hypertens"},{"key":"2247_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5349398","volume":"2019","author":"M Majzunova","year":"2019","unstructured":"Majzunova M, Kvandova M, Berenyiova A, Balis P, Dovinova I, Cacanyiova S. Chronic NOS inhibition affects oxidative state and antioxidant response differently in the kidneys of young normotensive and hypertensive rats. Oxid Med Cell Longev. 2019;2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/5349398.","journal-title":"Oxid Med Cell Longev"},{"key":"2247_CR64","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1097\/00004872-200312000-00027","volume":"21","author":"AP Fern\u00e1ndez","year":"2003","unstructured":"Fern\u00e1ndez AP, Serrano J, Castro S, Salazar FJ, L\u00f3pez JC, Rodrigo J, et al. Distribution of nitric oxide synthases and nitrotyrosine in the kidney of spontaneously hypertensive rats. J Hypertens. 2003;21:2375\u201388. https:\/\/doi.org\/10.1097\/00004872-200312000-00027.","journal-title":"J Hypertens"},{"key":"2247_CR65","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1046\/j.1523-1755.2002.00516.x","volume":"62","author":"XJ Zhou","year":"2002","unstructured":"Zhou XJ, Vaziri ND, Zhang J, Wang HW, Wang XQ. Association of renal injury with nitric oxide deficiency in aged SHR: Prevention by hypertension control with AT1 blockade. Kidney Int. 2002;62:914\u201321. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00516.x.","journal-title":"Kidney Int"},{"key":"2247_CR66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/hr.2013.99","volume":"37","author":"BF Heijnen","year":"2014","unstructured":"Heijnen BF, Van Essen H, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA. Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats. Hypertens Res. 2014;37:100\u20139. https:\/\/doi.org\/10.1038\/hr.2013.99.","journal-title":"Hypertens Res"},{"key":"2247_CR67","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.113.01295","volume":"62","author":"M Haloui","year":"2013","unstructured":"Haloui M, Tremblay J, Seda O, Koltsova SV, Maksimov GV, Orlov SN, et al. Increased renal epithelial Na channel expression and activity correlate with elevation of blood pressure in spontaneously hypertensive rats. Hypertension. 2013;62:731\u20137. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01295.","journal-title":"Hypertension"},{"key":"2247_CR68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00424-024-02916-1","volume":"476","author":"HP Santiago","year":"2024","unstructured":"Santiago HP, Leite LHR, Lima PMA, F\u00f3scolo DRC, Natali AJ, Pr\u00edmola-Gomes TN, et al. Effects of physical training on hypothalamic neuronal activation and expressions of vasopressin and oxytocin in SHR after running until fatigue. Pflug Arch Eur J Physiol. 2024;476:365\u201377. https:\/\/doi.org\/10.1007\/s00424-024-02916-1.","journal-title":"Pflug Arch Eur J Physiol"},{"key":"2247_CR69","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/01.HYP.5.4.476","volume":"5","author":"M Morris","year":"1983","unstructured":"Morris M, Keller M, Sundberg DK. Changes in paraventricular vasopressin and oxytocin during the development of spontaneous hypertension. Hypertension. 1983;5:476\u201381. https:\/\/doi.org\/10.1161\/01.HYP.5.4.476.","journal-title":"Hypertension"},{"key":"2247_CR70","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41440-024-01769-6","volume":"47","author":"M Jovanovi\u0107","year":"2024","unstructured":"Jovanovi\u0107 M, Stevanovi\u0107 B, Pajovi\u0107 V, Tasi\u0107 T, Lozi\u0107 M, \u0110uki\u0107 L, et al. Vasopressin and cardiovascular autonomic adjustment in chronic hypertensive pregnancy. Hypertens Res. 2024;47:2393\u2013404. https:\/\/doi.org\/10.1038\/s41440-024-01769-6.","journal-title":"Hypertens Res"},{"key":"2247_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0169-328X(88)90039-3","volume":"4","author":"HHM Van Tol","year":"1988","unstructured":"Van Tol HHM, Van Den Buuse M, De Jong W, Burbach JPH. Vasopressin and oxytocin gene expression in the supraoptic and paraventricular nucleus of the spontaneously hypertensive rat (SHR) during development of hypertension. Mol Brain Res. 1988;4:303\u201311. https:\/\/doi.org\/10.1016\/0169-328X(88)90039-3.","journal-title":"Mol Brain Res"},{"key":"2247_CR72","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0361-9230(80)80004-9","volume":"5","author":"A Negro-Vilar","year":"1980","unstructured":"Negro-Vilar A, Saavedra JM. Changes in brain somatostatin and vasopressin levels after stress in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res Bull. 1980;5:353\u20138. https:\/\/doi.org\/10.1016\/S0361-9230(80)80004-9.","journal-title":"Brain Res Bull"},{"key":"2247_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-079X.1992.tb00054.x","volume":"13","author":"BA Richardson","year":"1992","unstructured":"Richardson BA, Studier EH, Stallone JN, Kennedy CM. Effects of melatonin on water metabolism and renal function in male Syrian hamsters (Mesocricetus auratus). J Pineal Res. 1992;13:49\u201359. https:\/\/doi.org\/10.1111\/j.1600-079X.1992.tb00054.x.","journal-title":"J Pineal Res"},{"key":"2247_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41440-022-01044-6","volume":"46","author":"T Ogura","year":"2023","unstructured":"Ogura T, Kitada K, Morisawa N, Fujisawa Y, Kidoguchi S, Nakano D, et al. Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats. Hypertens Res. 2023;46:32\u20139. https:\/\/doi.org\/10.1038\/s41440-022-01044-6.","journal-title":"Hypertens Res"},{"key":"2247_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jpi.12287","volume":"60","author":"A Leibowitz","year":"2016","unstructured":"Leibowitz A, Volkov A, Voloshin K, Shemesh C, Barshack I, Grossman E. Melatonin prevents kidney injury in a high salt diet-induced hypertension model by decreasing oxidative stress. J Pineal Res. 2016;60:48\u201354. https:\/\/doi.org\/10.1111\/jpi.12287.","journal-title":"J Pineal Res"},{"key":"2247_CR76","doi-asserted-by":"publisher","unstructured":"Repov\u00e1-Bedn\u00e1rov\u00e1 K, Aziriov\u00e1 S, Hren\u00e1k J, Kraj\u010d\u00edrovi\u010dov\u00e1 K, Adamcov\u00e1 M, Paulis L, et al. Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24\u2009h light-induced hypertension. Physiol Res. 2013:S135\u201341. https:\/\/doi.org\/10.33549\/physiolres.932592.","DOI":"10.33549\/physiolres.932592"},{"key":"2247_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106659","volume":"127","author":"ZP Hu","year":"2020","unstructured":"Hu ZP, Fang XL, Sheng B, Guo Y, Yu YQ. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF\/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment. Vasc Pharmacol. 2020;127:106659. https:\/\/doi.org\/10.1016\/j.vph.2020.106659.","journal-title":"Vasc Pharmacol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02247-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:19:45Z","timestamp":1757182785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02247-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2247"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02247-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethical Committee for the Care and Use of Laboratory Animals at Comenius University in Bratislava, Slovak Republic and the State Veterinary Authority of Slovak Republic approved the experiments (Ro-1648\/19-221\/3). All experiments were conducted per recommendations of the ARRIVE guidelines, Guide for the Care and Use of Laboratory Animals and EU Directive 2010\/63\/EU for animal experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}